This inventor holds 2 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 1997.
Location History:
- Oakland, CA (US) (1997)
- Brookline, MA (US) (1997)
Company Filing History:
Years Active: 1997
Title: Therese M Anderson: Innovator in High-Pressure Impulse Transient Drug Delivery
Introduction
Therese M Anderson is a prominent inventor based in Oakland, CA, known for her groundbreaking work in the field of drug delivery systems. With a total of 2 patents, she has made significant contributions to enhancing the efficacy of therapeutic compounds.
Latest Patents
One of her latest patents is titled "Compound delivery using high-pressure impulse transients." This innovative method focuses on increasing the delivery of a compound from an exterior region to an interior region of a cell without causing substantial lethality to the cell. The process involves providing the compound in the exterior region proximal to the cell membrane and exposing the membrane to a time-dependent impulse transient characterized by a rise time and a magnitude. This exposure temporarily increases the permeability of the membrane, resulting in enhanced diffusion of the compound into the cell.
Another notable patent is "High-pressure impulse transient drug delivery for the treatment of diseases of cell proliferation." This method addresses the treatment of conditions such as neoplasms and rheumatoid arthritis by administering sub-toxic doses of a compound in combination with high-pressure impulse transients. The patent also outlines methods for identifying suitable compounds and impulse transient dosages for effective chemotherapy.
Career Highlights
Therese M Anderson is affiliated with The General Hospital Corporation, where she continues to advance her research and development in drug delivery technologies. Her work has the potential to revolutionize treatment protocols for various diseases, making her a key figure in the medical and scientific communities.
Collaborations
Throughout her career, Anderson has collaborated with esteemed colleagues, including Thomas J Flotte and Apostolos G Doukas. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Therese M Anderson's contributions to the field of drug delivery through her innovative patents demonstrate her commitment to improving medical treatments. Her work not only showcases her expertise but also highlights the importance of collaboration in advancing scientific research.